New science energizes the cancer market

Oncology drugs have had a prominent position in the biopharma industry, as well as healthcare generally, because the stakes are so high: cancer is often fatal; in its many forms, it is a common health condition; and, in recent years, […]

Read More

Health plan managers seek more information on drug utilization

EMD Serono’s Specialty Digest polls health plan managers (this year: 58 plans representing 173 million lives) on their challenges, accomplishments and opportunities in managing the use of specialty drugs among their ensured lives. Besides growing dramatically (specialty products now represent […]

Read More